NCT00099853
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
8,020 public trials
711 recruiting studies
Diabetes Mellitus, Type 2 trial results
Completed
Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes
NCT00821977
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Advanced Clinical Research Pell City, Alabama, United States
- Horizon Clinical Research Associates, PLLC Gilbert, Arizona, United States
- Vista Medical Research, Inc Mesa, Arizona, United States
- Clinical Research Advantage Mesa, Arizona, United States
NCT00765830
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +10 more
- Locations
-
- Clinica de Fracturas y Ortopedia Buenos Aires, Argentina
- Hospital Teodoro Alvarez Buenos Aires, Argentina
- Instituto de Investigaciones Clinicas de Mar del Plata Buenos Aires, Argentina
- Instituto Medico Especializado IME Buenos Aires, Argentina
Completed
Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes
NCT00106340
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
- Investigative Centers Nuremberg, Germany
NCT00616811
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- University of South Alabama Medical Center Mobile, Alabama, United States
- Anasazi Internal Medicine Phoenix, Arizona, United States
- University of Arkanasas for Medical Sciences Little Rock, Arkansas, United States
- Office of William Zigrang Burlingame, California, United States
NCT00383578
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Investigative Centers Nuremberg, Germany
- Novartis Pharmaceuticals Basel, Switzerland
Completed
Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes
NCT00102466
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Investigative Centers Nuremberg, Germany
- Novartis Pharmaceuticals Basel, Switzerland
NCT00396357
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
- Novartis Investigative Site Multiple Locations, Germany
NCT00770081
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +10 more
- Locations
-
- University of South Alabama Medical Center Mobile, Alabama, United States
- Anasazi Internal Medicine Phoenix, Arizona, United States
- Sonoran Health Specialists Scottsdale, Arizona, United States
- Mary K. Richards, MD. PA Little Rock, Arkansas, United States
NCT04667728
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Clínica de Medicina Familiar Oriente México, Mexico